Mozart Therapeutics is a biotech startup focusing on the development of disease-modifying therapies for autoimmune and inflammatory diseases. The company is using a novel regulatory CD8 T cell network to create disease-modifying CD8 Treg modulators for a variety of autoimmune diseases. Mozart is developing a pipeline of first-in-class 'CD8Treg modulators with the goal of restoring long-term immune balance and preventing the progressive damage caused by an autoreactive and pathogenic immune response.

Biotechnology

Mozart Therapeutics

Mozart Therapeutics' headquarters in Seattle, WA, United States

Katie Fanning

Russ Hawkinson

Jennifer More

Kristine Swiderek

Gerald T. Nepom

Jasmina Marjanovic

Marie-Claire Peakman

Henrijette Richter

Tom Daniel

Fabio Pucci

Mark M. Davis

Steven Gillis

Peter Dudek

Julie Gilmore

Calvin Kuo

Michael Rosenblum

K. Christopher Garcia

Description

People (14)

Courtney Crane

Jennifer Gardell

Brent Meengs

Meghan Maurer

Monica Anderson Childs

Nadine Morgan

Jennifer More

Dan Patton

Daniel Boster

Susan Julien

Jon Henry Therriault

Rachel Keylin

Russ Hawkinson

Kristi Manjarrez

Jobs